From diagnosis to treatment and ongoing condition management, the patient journey is becoming an increasingly digitised one – a process which has been massively accelerated by the Covid pan
Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find.
As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022?
After two FDA rejections for non-alcoholic steatohepatitis (NASH) therapy obeticholic acid (OCA), Intercept Pharma has agreed to be taken over by Italian drugmaker Alfasig
Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho
